Docetaxel

Šalis: Naujoji Zelandija

kalba: anglų

Šaltinis: Medsafe (Medicines Safety Authority)

Veiklioji medžiaga:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Prieinama:

REX Medical Ltd

INN (Tarptautinis Pavadinimas):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Dozė:

80 mg/mL

Vaisto forma:

Concentrate for infusion

Sudėtis:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Vienetai pakuotėje:

Vial, glass, Diluent, 6 mL

Klasė:

Prescription

Recepto tipas:

Prescription

Pagaminta:

Cipla Ltd

Terapinės indikacijos:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Produkto santrauka:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Leidimo data:

2006-06-23